This landmark study is the first-ever side-by-side comparison of 171 antibodies against Ebola virus.
A one-two punch of powerful antibodies may be the best way to stop Ebola virus, reports an international team of scientists in the journal Cell. Their findings suggest new therapies should disable Ebola virus’s infection machinery and spark the patient’s immune system to call in reinforcements.
“This study presents results from an unprecedented international collaboration and demonstrates how 43 previously competing labs can together accelerate therapeutics and vaccine design,” says Erica Ollmann Saphire, PhD, professor at Scripps Research and director of the Viral Hemorrhagic Fever Immunotherapeutic Consortium (VIC).
From 2013–2016, West Africa faced the deadliest Ebola outbreak the world has ever seen. By the time the outbreak was declared over, 11,325 people had died. The VIC is an international group of the world’s leading virologists, immunologists, systems biologists and structural biologists working to stop an outbreak on that scale from ever striking again.
The VIC researchers aim to understand which Ebola-fighting antibodies are best—and why. The hope is that the most effective antibodies can be combined in a therapeutic “cocktail.” Unlike an Ebola vaccine, these cocktails could be given to those already infected, which is important for stopping a disease that tends to emerge unexpectedly in remote locations.
Ollmann Saphire and her colleagues in the VIC have published more than 40 studies in just the last five years. This landmark study is the first-ever side-by-side comparison of 171 antibodies against Ebola virus and other related viruses, known as filoviruses. All antibodies in the panel were donated by different labs around the world, and many had not been previously characterized in such extensive detail.
“Through the VIC, we could test a larger pool of antibodies in parallel, which increased the potential to detect statistically significant relationships between antibody features and protection,” says Saphire. “We used this global pool of antibodies to evaluate, and streamline, the research pipeline itself.”
In addition to identifying links between antibody target locations and activity, VIC researchers tested this huge pool of antibodies to reveal which antibodies “neutralized” the virus, why neutralization assays so often disagree, and whether or not neutralization in test tubes adequately predicted how well these antibodies would protect live animals from Ebola virus infection. Unexpectedly, neutralization alone was not always associated with the protective ability of an antibody.
Notably, the scientists found nine antibodies that protected mice from infection without neutralizing the virus in test tubes. These antibodies likely fight infection by interacting with an infected person’s immune system, helping orchestrate a better immune response to the virus.
This “immune effector” activity is featured in the team’s companion study published simultaneously in Cell Host & Microbe. “The ability to evoke an immune response will likely represent a new avenue of study for therapeutic antibodies for Ebola virus infection,” says Sharon Schendel, project manager for the VIC and science writer in the Saphire lab.
From the large body of results, VIC member and Scripps Research faculty member Kristian Andersen, PhD, and his graduate student Karthik Gangavarapu developed a network describing how each antibody feature correlates to protection, which can serve as a guide to predict whether newly identified antibodies will have therapeutic value. Saphire says the next steps for the VIC are to further test promising antibody cocktails in non-human primates. The team will also pursue engineering of antibodies that carry signature features to better drive immune system response.
The Latest on: Ebola
via Google News
The Latest on: Ebola
- A successful Ebola vaccine delivery shows how a Covid-19 vaccine would work in Africaon November 23, 2020 at 11:01 am
There have been growing concerns the very low-temperature requirements for the promising Covid-19 vaccine candidates developed by Pfizer and Moderna will lead to storage and logistics challenges that ...
- Congo declares end to 11th Ebola outbreakon November 20, 2020 at 8:04 pm
Congo has announced the end to its 11th Ebola outbreak, this case in the western Equateur Province. The declaration, which occurred more than 42 days after two tests came back negative for the ...
- Ebola virus disease – Democratic Republic of the Congoon November 19, 2020 at 7:29 am
On 18 November 2020, the Minister of Health of the Democratic Republic of the Congo declared the end of the Ebola Virus Disease (EVD) outbreak in Equateur Province.
- Congo’s Latest Ebola Outbreak Declared Finishedon November 19, 2020 at 7:11 am
The disease killed at least 55 people in an outbreak that began June 1, the 11th bout of Ebola to strike the Democratic Republic of Congo.
- Democratic Republic of the Congo declares the end to its 11th Ebola outbreakon November 18, 2020 at 10:14 pm
The Democratic Republic of Congo (DRC) officially declared the end of its 11th Ebola outbreak Wednesday, six months after the first cases of the deadly virus were reported.
- Congo Is Ebola-Free for First Time in More Than Two Yearson November 18, 2020 at 12:05 pm
Victory against the deadly viral disease came as the African country was also battling a simultaneous coronavirus outbreak.
- Congo declares end of Ebola outbreak, sees lessons for COVID fighton November 18, 2020 at 10:32 am
Democratic Republic of Congo announced the end of an almost six-month Ebola outbreak in the west of the country on Wednesday as health authorities looked to apply lessons from the successful response ...
- WHO announces end to Ebola outbreak in Congoon November 18, 2020 at 5:47 am
The World Health Organization (WHO) on Wednesday announced the end to the 11th Ebola outbreak in Congo. The country's minister of health, Eteni Longondo, joined the WHO in a statement noting the first ...
- Congo declares end of Ebola outbreak that killed 55on November 18, 2020 at 5:16 am
Democratic Republic of Congo's health minister on Wednesday announced the end of an Ebola outbreak in the west of the country that infected 130 people and killed 55.
via Bing News